Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Litsa Karageorgos

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta. Proteins and Proteomics|December 24, 2016
Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillationLungisa Bickle, John J Hopwood, Litsa Karageorgos
Journal of Inherited Metabolic Disease|October 28, 2010
Gaucher disease in sheepLitsa Karageorgos, Malcolm J Lancaster, Judith S Nimmo, et al.
Cytotherapy|April 8, 2010
Genetic manipulation of murine embryonic stem cells with enhanced green fluorescence protein and sulfatase-modifying factor I genesGuoying Zhao, Litsa Karageorgos, Rhonda G Hutchinson, et al.
Molecular Genetics and Metabolism|May 24, 2017
Lipid composition of microdomains is altered in neuronopathic Gaucher disease sheep brain and spleenLeanne K Hein, Tina Rozaklis, Melissa K Adams, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 31, 2023
The ovine Type II Gaucher disease model recapitulates aspects of human brain diseaseLeanne K Winner, Helen Beard, Litsa Karageorgos, et al.
Molecular Genetics and Metabolism|June 28, 2005
An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrumDoug A Brooks, Gary J Gibson, Litsa Karageorgos, et al.
Human Mutation|August 18, 2018
Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB geneRosella Tomanin, Litsa Karageorgos, Alessandra Zanetti, et al.
Neurobiology of Disease|March 16, 2016
Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher diseaseLitsa Karageorgos, Leanne Hein, Tina Rozaklis, et al.
JIMD Reports|November 7, 2013
Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured CellsMakoto Kamei, Karissa Kasperski, Maria Fuller, et al.
Molecular Genetics and Metabolism|December 13, 2006
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapyLitsa Karageorgos, Doug A Brooks, Paul Harmatz, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta. Proteins and Proteomics|December 24, 2016
Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillationLungisa Bickle, John J Hopwood, Litsa Karageorgos
Journal of Inherited Metabolic Disease|October 28, 2010
Gaucher disease in sheepLitsa Karageorgos, Malcolm J Lancaster, Judith S Nimmo, et al.
Cytotherapy|April 8, 2010
Genetic manipulation of murine embryonic stem cells with enhanced green fluorescence protein and sulfatase-modifying factor I genesGuoying Zhao, Litsa Karageorgos, Rhonda G Hutchinson, et al.
Molecular Genetics and Metabolism|May 24, 2017
Lipid composition of microdomains is altered in neuronopathic Gaucher disease sheep brain and spleenLeanne K Hein, Tina Rozaklis, Melissa K Adams, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 31, 2023
The ovine Type II Gaucher disease model recapitulates aspects of human brain diseaseLeanne K Winner, Helen Beard, Litsa Karageorgos, et al.
Molecular Genetics and Metabolism|June 28, 2005
An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrumDoug A Brooks, Gary J Gibson, Litsa Karageorgos, et al.
Human Mutation|August 18, 2018
Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB geneRosella Tomanin, Litsa Karageorgos, Alessandra Zanetti, et al.
Neurobiology of Disease|March 16, 2016
Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher diseaseLitsa Karageorgos, Leanne Hein, Tina Rozaklis, et al.
JIMD Reports|November 7, 2013
Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured CellsMakoto Kamei, Karissa Kasperski, Maria Fuller, et al.
Molecular Genetics and Metabolism|December 13, 2006
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapyLitsa Karageorgos, Doug A Brooks, Paul Harmatz, et al.
Pageof 3